Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

Ilaria Colombo, Stephanie Lheureux, Amit Manulal Oza Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada Abstract: Rucaparib is a potent small-molecule inhibitor of poly (ADP-ribose) polymerase (PARP) proteins (PARP-1, PARP-2...

Full description

Bibliographic Details
Main Authors: Colombo I, Lheureux S, Oza AM
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/rucaparib-a-novel-parp-inhibitor-for-brca-advanced-ovarian-cancer-peer-reviewed-article-DDDT